QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NYSE:TLYS

Tilly's (TLYS) Stock Price, News & Analysis

$5.75
+0.17 (+3.05%)
(As of 04:38 PM ET)
Today's Range
$5.44
$5.86
50-Day Range
$5.45
$7.73
52-Week Range
$5.34
$9.50
Volume
106,293 shs
Average Volume
89,733 shs
Market Capitalization
$172.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.88

Tilly's MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
37.0% Upside
$7.88 Price Target
Short Interest
Bearish
2.62% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.57mentions of Tilly
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$2.78 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.61) to ($0.24) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.41 out of 5 stars

Retail/Wholesale Sector

132nd out of 195 stocks

Apparel & Accessory Stores Industry

1st out of 6 stocks

TLYS stock logo

About Tilly's Stock (NYSE:TLYS)

Tilly's, Inc. operates as a specialty retailer of casual apparel, footwear, accessories, and hardgoods for young men and women, and boys and girls in the United States. Its apparel merchandise includes tops, outerwear, bottoms, swim, and dresses; and accessories merchandise comprises backpacks, hydration bottles, hats, sunglasses, small electronics and accessories, handbags, watches, jewelry, and others. The company also provides third-party merchandise assortment across its various product categories. The company sells its merchandise through its stores and e-commerce website, www.tillys.com. Tilly's, Inc. was founded in 1982 and is headquartered in Irvine, California.

TLYS Stock Price History

TLYS Stock News Headlines

Tilly's (NYSE:TLYS) Rating Increased to Hold at StockNews.com
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
1 Dividend Stock Down 11 Percent to Buy Right Now
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Why Tilly's (TLYS) Stock Is Falling Today
Tilly's: Fiscal Q4 Earnings Snapshot
Recap: Tilly's Q4 Earnings
Tilly's Q4 2024 Earnings Preview
Tilly's (TLYS) Q4 Earnings: What To Expect
TLYS Oct 2024 12.500 call
See More Headlines
Receive TLYS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tilly's and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/14/2024
Today
4/19/2024
Next Earnings (Estimated)
6/06/2024
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Industry
Apparel & accessory stores
Sub-Industry
Apparel Retail
CUSIP
88688510
Employees
6,048
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.88
High Stock Price Target
$8.25
Low Stock Price Target
$7.50
Potential Upside/Downside
+37.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$-34,490,000.00
Pretax Margin
-4.14%

Debt

Sales & Book Value

Annual Sales
$623.08 million
Book Value
$4.83 per share

Miscellaneous

Free Float
21,593,000
Market Cap
$172.33 million
Optionable
Optionable
Beta
1.58
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

TLYS Stock Analysis - Frequently Asked Questions

Should I buy or sell Tilly's stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tilly's in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" TLYS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TLYS, but not buy additional shares or sell existing shares.
View TLYS analyst ratings
or view top-rated stocks.

What is Tilly's' stock price target for 2024?

3 Wall Street research analysts have issued 1-year target prices for Tilly's' stock. Their TLYS share price targets range from $7.50 to $8.25. On average, they expect the company's stock price to reach $7.88 in the next year. This suggests a possible upside of 37.0% from the stock's current price.
View analysts price targets for TLYS
or view top-rated stocks among Wall Street analysts.

How have TLYS shares performed in 2024?

Tilly's' stock was trading at $7.54 on January 1st, 2024. Since then, TLYS stock has decreased by 23.7% and is now trading at $5.75.
View the best growth stocks for 2024 here
.

When is Tilly's' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 6th 2024.
View our TLYS earnings forecast
.

How were Tilly's' earnings last quarter?

Tilly's, Inc. (NYSE:TLYS) posted its quarterly earnings data on Thursday, March, 14th. The specialty retailer reported ($0.17) earnings per share for the quarter, beating analysts' consensus estimates of ($0.22) by $0.05. The specialty retailer had revenue of $173.02 million for the quarter, compared to analyst estimates of $171.65 million. Tilly's had a negative net margin of 5.54% and a negative trailing twelve-month return on equity of 11.93%.

What guidance has Tilly's issued on next quarter's earnings?

Tilly's issued an update on its first quarter 2024 earnings guidance on Thursday, March, 14th. The company provided earnings per share guidance of -0.540--0.420 for the period, compared to the consensus EPS estimate of -0.400. The company issued revenue guidance of $109.0 million-$119.0 million, compared to the consensus revenue estimate of $124.1 million.

What is Edmond Thomas' approval rating as Tilly's' CEO?

97 employees have rated Tilly's Chief Executive Officer Edmond Thomas on Glassdoor.com. Edmond Thomas has an approval rating of 71% among the company's employees.

What other stocks do shareholders of Tilly's own?
How do I buy shares of Tilly's?

Shares of TLYS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:TLYS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners